Dr. Igor Gonda, Ph.D. is the President, Chief Executive Officer, Director of Aradigm Corporationration He has served as the company President and Chief Executive Officer since August 2006 and as a director since September 2001. From December 2001 to August 2006, Dr. Gonda was the Chief Executive Officer and Managing Director of Acrux Limited, a publicly traded specialty pharmaceutical company located in Melbourne, Australia. From July 2001 to December 2001, Dr. Gonda was the company Chief Scientific Officer and, from October 1995 to July 2001, was the company Vice President, Research and Development. From February 1992 to September 1995, Dr. Gonda was a Senior Scientist and Group Leader at Genentech, Inc. His key responsibilities at Genentech were the development of the inhalation delivery of rhDNase for the treatment of cystic fibrosis and nonparenteral methods of delivery of biologics. Prior to that, Dr. Gonda held academic positions at the University of Aston in Birmingham, United Kingdom, and the University of Sydney, Australia. Dr. Gonda holds a B.Sc. in Chemistry and a Ph.D. in Physical Chemistry from Leeds University, United Kingdom. Dr. Gonda was the Chairman of the company Scientific Advisory Board until August 2006.
The company has accumulated 8.27 M in total debt. Aradigm Corporation has Current Ratio of 7.34 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Aradigm Corporationration, a specialty pharmaceutical company, engages in the development and commercialization of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. Aradigm Corporation [ARDM] is traded as part of a regulated electronic trading service offered by the NASD. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
OTC BB Aradigm Corporation
-0.35%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
